AXSPA

Clinical trials for AXSPA explained in plain language.

Never miss a new study

Get alerted when new AXSPA trials appear

Sign up with your email to follow new studies for AXSPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug hopes to ease joint pain for arthritis sufferers

Disease control Recruiting now

This study tests a new medicine called SPY002-072 in adults with moderate-to-severe rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. About 285 participants will receive either the drug or a placebo to see if it reduces joint swelling and pain. The goal is to…

Matched conditions: AXSPA

Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

AXSPA

Get alerted when new AXSPA trials appear

New drug hopes to ease joint pain for arthritis sufferers